These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 27289208)
1. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes. Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208 [TBL] [Abstract][Full Text] [Related]
3. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. Barrio R; Bellanné-Chantelot C; Moreno JC; Morel V; Calle H; Alonso M; Mustieles C J Clin Endocrinol Metab; 2002 Jun; 87(6):2532-9. PubMed ID: 12050210 [TBL] [Abstract][Full Text] [Related]
4. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients. Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192 [TBL] [Abstract][Full Text] [Related]
5. Screening of mutations in the GCK gene in Jordanian maturity-onset diabetes of the young type 2 (MODY2) patients. Khalil R; Al-Sheyab F; Khamaiseh E; Halaweh MA; Abder-Rahman HA Genet Mol Res; 2009 May; 8(2):500-6. PubMed ID: 19551638 [TBL] [Abstract][Full Text] [Related]
6. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245 [TBL] [Abstract][Full Text] [Related]
7. MODY2 caused by a novel mutation of GCK gene. Pulst K; Arbo T; Kahre T; Peet A; Tillmann V J Pediatr Endocrinol Metab; 2012; 25(7-8):801-3. PubMed ID: 23155715 [TBL] [Abstract][Full Text] [Related]
8. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L; Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900 [TBL] [Abstract][Full Text] [Related]
9. GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature. Ping Xiao Y; Hua Xu X; Lan Fang Y; Jiang L; Chen C; Liang L; Lin Wang C J Pediatr Endocrinol Metab; 2016 Aug; 29(8):959-64. PubMed ID: 27269892 [TBL] [Abstract][Full Text] [Related]
10. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY. Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781 [TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of a Novel Heterozygous Mutation in the Glucokinase Gene That Causes MODY2 in Chinese Pedigrees. Jiang F; Yan J; Zhang R; Ma X; Bao Y; Gu Y; Hu C Front Endocrinol (Lausanne); 2021; 12():803992. PubMed ID: 34956103 [TBL] [Abstract][Full Text] [Related]
12. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. DellaManna T; Silva MR; Chacra AR; Kunii IS; Rolim AL; Furuzawa G; Maciel RM; Reis AF Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):490-5. PubMed ID: 23295287 [TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY). Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678 [TBL] [Abstract][Full Text] [Related]
15. Characterization of glucokinase polymorphisms associated with maturity-onset diabetes of the young (MODY2) in Jordanian population. Al-Sheyab F; Khamaiseh E; Halaweh MA; Khaul RW Tsitol Genet; 2009; 43(5):58-63. PubMed ID: 20458967 [TBL] [Abstract][Full Text] [Related]
17. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs. Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity. García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the GCK gene in 79 MODY type 2 patients: A multicenter Turkish study, mutation profile and description of twenty novel mutations. Aykut A; Karaca E; Onay H; Gökşen D; Çetinkalp Ş; Eren E; Ersoy B; Çakır EP; Büyükinan M; Kara C; Anık A; Kırel B; Özen S; Atik T; Darcan Ş; Özkınay F Gene; 2018 Jan; 641():186-189. PubMed ID: 29056535 [TBL] [Abstract][Full Text] [Related]
20. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pruhova S; Dusatkova P; Sumnik Z; Kolouskova S; Pedersen O; Hansen T; Cinek O; Lebl J Pediatr Diabetes; 2010 Dec; 11(8):529-35. PubMed ID: 20337973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]